drugset / Trial / NCT04001998

Healthy Volunteer Study Comparing Tablet and Capsule Formulations

NCT04001998 ↗

Phase 1 Withdrawn Blade Therapeutics
RandomizedCrossoverOpen-labelTreatment

Summary

Single center, randomized, open label, two-part crossover study designed to evaluate the PK, food effect, dose proportionality, safety, and tolerability of BLD-2660 in healthy volunteers.

Timeline

Start
2021-02
Primary completion
2021-06
Completion
2021-07

Outcome

Outcome not reported

Stopped: “On hold to determine chosen formulations”

Drugs

EvaluationDrugModalityDoseRoute
Subject DAZCAPISTAT Small molecule — Oral

Indications

No indication recorded.